EPISODE · Jan 18, 2024 · 8 MIN
Thursday, January 18, 2024
from The Gist Healthcare Podcast
Venture capital firm General Catalyst’s healthcare arm plans to purchase Akron, Ohio-based Summa Health, and turn it into a for-profit system. CMS issues a final rule that aims to streamline health insurer prior authorizations. And, the FDA approves a groundbreaking CRISPR treatment for a second blood disease. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
Venture capital firm General Catalyst’s healthcare arm plans to purchase Akron, Ohio-based Summa Health, and turn it into a for-profit system. CMS issues a final rule that aims to streamline health insurer prior authorizations. And, the FDA approves a groundbreaking CRISPR treatment for a second blood disease. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Thursday, January 18, 2024
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m